1 year return (CAGR)
-31.71%
Y mAbs Therapeutics Exchange (NASDAQ, USD)
YMAB
-
+0.01 (+0.12%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-21.66%
5 year return (CAGR)
-26.22%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
387.59M
Price/Sales
4.58
Ent value
347.96M
Price/Book
4.19
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-20.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreDownside potential
Loading...
Downside potential data
| YMAB | S&P500 | |
| Current price drop from All-time high | -84.13% | -0.14% |
| Highest price drop | -94.78% | -56.47% |
| Date of highest drop | 22 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -54.77% | -10.68% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 1174 days | 1805 days |
News
No items found